Menopausal age, postmenopausal hormone therapy and incident atrial fibrillation.

ABSTRACT:

Objective

Limited data exist on the association between menopause and atrial fibrillation (AF). We sought to examine the relationship between menopausal age, postmenopausal hormone therapy (PHT) use and incident AF.

Methods

The Women's Health Study (WHS) enrolled 39 876 female health professionals between 1992 and 1995. We prospectively examined 30 034 women in WHS using Cox proportional-hazard models. Participants were free of cardiovascular disease and AF at baseline and had not undergone hysterectomy without bilateral oophorectomy prior to menopause. Incident AF was confirmed by medical record review.

Results

At baseline, median age was 53 years (IQR 49-60), median menopausal age was 50 years (IQR 46-52) and 14 415 (48.0%) had prior PHT use. Over a median follow-up

SUBMITTER: Wong JA 

PROVIDER: S-EPMC5831356 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature